Inotiv acquires laboratory instrumentation for discovery and development of novel therapies

West lafayette, ind., july 15, 2021 (globe newswire) -- inotiv, inc. (nasdaq: notv ) (the “company”, “we”, “our” or “inotiv”), a leading contract research organization specializing in nonclinical and bioanalytical drug discovery and development services, today announced that the company has purchased the physical assets of a tennessee-based laboratory services provider that ceased operations. the assets, which include lab instrumentation, stock consumables and chemicals, lab benchwork, and office furniture, were acquired for approximately $1.3 million, a substantial discount to the company's estimate of fair market value.
NOTV Ratings Summary
NOTV Quant Ranking